What is Alpha Biosciences?
Alpha Biosciences operates as a critical infrastructure provider within the microbiological and molecular biology landscape. By specializing in the production of essential culture media, peptones, and agars, the company serves as a foundational partner for industries ranging from food safety and water treatment to cosmetics and healthcare. Their adherence to ISO 9001:2015 standards positions them as a high-reliability supplier in a market where precision and quality control are paramount. Through the development of custom media solutions, Alpha Biosciences effectively bridges the gap between raw material manufacturing and complex laboratory application, ensuring that clients in the food and beverage, environmental, and clinical sectors maintain rigorous testing standards.
How much funding has Alpha Biosciences raised?
Alpha Biosciences has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Alpha Biosciences
PPP
Public-Private Partnership
What's next for Alpha Biosciences?
The infusion of capital from this late-stage financing round is expected to catalyze Alpha Biosciences' expansion into new geographic markets and accelerate the development of its proprietary molecular biology product lines. As the company transitions into this next phase of maturity, the focus will likely shift toward optimizing supply chain efficiencies and deepening its penetration into the global food safety testing market. By leveraging its established reputation for quality, the firm is well-positioned to capitalize on the increasing demand for standardized microbiological testing protocols, potentially exploring strategic partnerships or facility upgrades to meet the evolving needs of its diverse industrial client base.
See full Alpha Biosciences company page
